Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation
- 1 December 2000
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 111 (3), 745-753
- https://doi.org/10.1046/j.1365-2141.2000.02470.x
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Regulatory Function of Factor-XIIIa-Positive Dendrocytes in Incipient Toxic Epidermal Necrolysis and Graft-versus-Host ReactionDermatology, 1999
- Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effectLeukemia, 1997
- The treatment of relapsed or refractory intermediate grade non-Hodgkin’s lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferonBone Marrow Transplantation, 1997
- Graft-versus-myeloma effect in two casesThe Lancet, 1996
- Interferon-γ Potentiates the Antitumor Effect of Cyclosporine-Induced AutoimmunityJournal of Hematotherapy, 1992
- Cyclosporine-induced graft-versus-host disease after autologous bone marrow transplantation in hematological malignanciesAnnals of Hematology, 1991
- Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1987
- A Randomized Study of the Prevention of Acute Graft-versus-Host DiseaseNew England Journal of Medicine, 1982
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979